Paper42650331
PDA Treatment Strategy and Pulmonary Hemorrhage Risk in Very Low Birth Weight Infants: A Nationwide Cohort Study.
Shin JA and 2 others. Children (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. PDA Treatment Strategy and Pulmonary Hemorrhage Risk in Very Low Birth Weight Infants: A Nationwide Cohort Study. Papers, record 42650331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42650331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PDA Treatment Strategy and Pulmonary Hemorrhage Risk in Very Low Birth Weight Infants: A Nationwide Cohort Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31222841 | Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31222841 | PubMed |
| 2 | 40191647 | A decision tree analysis to predict massive pulmonary hemorrhage in extremely low birth weight infants: a nationwide large cohort database. | Front Pediatr | 2025 | https://conductscience.org/library/papers/40191647 | PubMed |
| 3 | 30340932 | PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. | J Pediatr | 2019 | https://conductscience.org/library/papers/30340932 | PubMed |
| 4 | 18245398 | Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. | Pediatrics | 2008 | https://conductscience.org/library/papers/18245398 | PubMed |
| 5 | 32045960 | Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32045960 | PubMed |
| 6 | 31985831 | Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/31985831 | PubMed |
| 7 | 40722815 | Pulmonary Hemorrhage in Premature Infants: Pathophysiology, Risk Factors and Clinical Management. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722815 | PubMed |
| 8 | 26566355 | The Korean Neonatal Network: An Overview. | J Korean Med Sci | 2015 | https://conductscience.org/library/papers/26566355 | PubMed |
| 9 | 29584842 | Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis. | JAMA | 2018 | https://conductscience.org/library/papers/29584842 | PubMed |
| 10 | 28680875 | Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants. | Front Pediatr | 2017 | https://conductscience.org/library/papers/28680875 | PubMed |
| 11 | 32012227 | Surfactant for pulmonary haemorrhage in neonates. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32012227 | PubMed |
| 12 | 1735851 | Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. | J Pediatr | 1992 | https://conductscience.org/library/papers/1735851 | PubMed |
| 13 | 34692607 | Conservative Treatment Without Any Intervention Compared With Other Therapeutic Strategies for Symptomatic Patent Ductus Arteriosus in Extremely Preterm Infants: A Nationwide Cohort Study in Korea. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34692607 | PubMed |
| 14 | 38658692 | Prophylactic indomethacin and the risk of serious pulmonary hemorrhages in preterm infants less than 28 weeks' gestation. | J Perinatol | 2024 | https://conductscience.org/library/papers/38658692 | PubMed |
| 15 | 40288780 | Patent Ductus Arteriosus in Preterm Infants. | Pediatrics | 2025 | https://conductscience.org/library/papers/40288780 | PubMed |
| 16 | 40548426 | Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40548426 | PubMed |
| 17 | 20614421 | Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20614421 | PubMed |
| 18 | 40423988 | Active Treatment vs Expectant Management of Patent Ductus Arteriosus in Preterm Infants: A Meta-Analysis. | JAMA Pediatr | 2025 | https://conductscience.org/library/papers/40423988 | PubMed |
| 19 | 37039501 | Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37039501 | PubMed |
| 20 | 26103028 | Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants. | JAMA | 2015 | https://conductscience.org/library/papers/26103028 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42650331
GET https://conductscience.org/api/papers/v1/42650331/references?page=2